<b>Independent Pharmacy Access and Resilience Pilot Program; report; sunset.</b> Establishes the Independent Pharmacy Access and Resilience Pilot Program in the Department of Health to strengthen and stabilize access to pharmacy services in medically underserved communities and communities at heightened risk of pharmacy closure. The Program is established as a pilot program with an expiration date of July 1, 2030, and participation is limited to 12 independent pharmacies meeting certain criteria outlined in the bill. The bill directs the Department to submit to the Governor and General Assembly an interim report with evaluations of participating pharmacies no later than November 1, 2028, and a final comprehensive evaluation no later than November 1, 2029, in order for the General Assembly to determine whether to continue, modify, expand, or terminate the Program.
Raw source record
{
"id": 84135,
"url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/hb335\/",
"tags": {
"152665": "pharmacy",
"152666": "healthcare",
"152667": "pilot program",
"152668": "underserved communities",
"152669": "report",
"152670": "access",
"152675": "health",
"152676": "community"
},
"text": [
{
"date": "2026-01-11",
"number": "HB335",
"pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb335.pdf"
}
],
"type": "bill",
"year": 2026,
"video": null,
"number": "hb335",
"patron": "Anthony, Bonita",
"status": "failed committee",
"chamber": "house",
"changes": null,
"outcome": "failed",
"related": [
{
"id": 85782,
"name": "Finance",
"year": 2026,
"count": 4,
"number": "sb721",
"status": "failed committee",
"catch_line": "Maternal Health Monitoring Pilot Program; established, report.",
"date_introduced": "January 14, 2026"
},
{
"id": 85959,
"name": null,
"year": 2026,
"count": 3,
"number": "hb1452",
"status": "signed by governor",
"catch_line": "Medicaid; expedited review process for service authorization requests, report.",
"date_introduced": "January 22, 2026"
},
{
"id": 85248,
"name": "Finance",
"year": 2026,
"count": 3,
"number": "sb308",
"status": "signed by governor",
"catch_line": "Drug overdose and drug overdose deaths; VDH to develop plan for opioid overdose response.",
"date_introduced": "January 13, 2026"
},
{
"id": 85418,
"name": null,
"year": 2026,
"count": 3,
"number": "hb1337",
"status": "signed by governor",
"catch_line": "State Health Services Plan Task Force; designated areas of state in need of additional project.",
"date_introduced": "January 19, 2026"
},
{
"id": 84899,
"name": "Education and Health",
"year": 2026,
"count": 3,
"number": "sb239",
"status": "signed by governor",
"catch_line": "State Health Services Plan Task Force; designated areas of state in need of additional project.",
"date_introduced": "January 12, 2026"
}
],
"summary": "<b>Independent Pharmacy Access and Resilience Pilot Program; report; sunset.<\/b> Establishes the Independent Pharmacy Access and Resilience Pilot Program in the Department of Health to strengthen and stabilize access to pharmacy services in medically underserved communities and communities at heightened risk of pharmacy closure. The Program is established as a pilot program with an expiration date of July 1, 2030, and participation is limited to 12 independent pharmacies meeting certain criteria outlined in the bill. The bill directs the Department to submit to the Governor and General Assembly an interim report with evaluations of participating pharmacies no later than November 1, 2028, and a final comprehensive evaluation no later than November 1, 2029, in order for the General Assembly to determine whether to continue, modify, expand, or terminate the Program.",
"version": "HB335",
"copatron": [
{
"shortname": "neclark",
"partisanship": 13,
"name_formatted": "Del. Nadarius Clark (D-Portsmouth)"
},
{
"shortname": "jgcole",
"partisanship": 19,
"name_formatted": "Del. Josh Cole (D-Fredericksburg)"
},
{
"shortname": "erguzman",
"partisanship": 16,
"name_formatted": "Del. Elizabeth Guzman (D-Woodbridge)"
},
{
"shortname": "rahenson",
"partisanship": 13,
"name_formatted": "Del. Rozia Henson (D-Woodbridge)"
},
{
"shortname": "chschmidt",
"partisanship": null,
"name_formatted": "Del. Charlie Schmidt (D-Richmond)"
},
{
"shortname": "rtwillett",
"partisanship": 18,
"name_formatted": "Del. Rodney Willett (D-Henrico)"
},
{
"shortname": "awgraves",
"partisanship": 15,
"name_formatted": "Del. Angelia Williams Graves (D-Norfolk)"
},
{
"shortname": "dwmarsden",
"partisanship": 29,
"name_formatted": "Sen. Dave Marsden (D-Burke)"
}
],
"committee": "Appropriations",
"full_text": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=enactcls>1. That the Code of Virginia is amended by adding in Chapter 1 of Title 32.1 an article numbered 3.1, consisting of sections numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.8\/'>32.1-23.8<\/a> through <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.13\/'>32.1-23.13<\/a>, as follows:<\/p>\n<p class=textctr><ins>Article <\/ins><ins>3.1<\/ins><ins>.<\/ins><\/p>\n<p class=textctr><ins>Independent Pharmacy Access and Resilience Pilot Program<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23\/'>32.1-23<\/a>.<\/ins><ins>8<\/ins><ins>.<\/ins><ins> Independent Pharmacy Access and Resilience Pilot Program<\/ins><ins> established<\/ins><ins>; purpose.<\/ins><\/p>\n<p class=section><ins>There is hereby created in the Department the Independent Pharmacy Access and Resilience Pilot Program (the Program)<\/ins><ins>. The purpose of the Program is<\/ins><ins> to strengthen and stabilize access to pharmacy services in medically underserved communities and communities at heightened risk of pharmacy closure. The Program shall support development of sustainable pharmacy infrastructure, expansion of clinical services within pharmacists' scope of practice, partnership development, and implementation of technology that improves access, efficiency, and care coordination.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23\/'>32.1-23<\/a>.<\/ins><ins>9<\/ins><ins>. <\/ins><ins>Pre-implementation <\/ins><ins>phase:<\/ins><ins> preliminary <\/ins><ins>identification <\/ins><ins>of communities,<\/ins><ins>and planning<\/ins><ins>; report<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>During <\/ins><ins>f<\/ins><ins>iscal <\/ins><ins>y<\/ins><ins>ear 2026<\/ins><ins>\u2013<\/ins><ins>2027,<\/ins><ins> using currently existing appropriated funds,<\/ins><ins> the Department shall engage in<\/ins><ins> the <\/ins><ins>identification of <\/ins><ins>communities<\/ins><ins> with limited pharmacy access, including those that meet <\/ins><ins>one or more of the following criteria:<\/ins><\/p>\n<p class=section><ins>1. <\/ins><ins>Is a w<\/ins><ins>hole-locality pharmacy desert<\/ins><ins> <\/ins><ins>status;<\/ins><\/p>\n<p class=section><ins>2. <\/ins><ins>Is a c<\/ins><ins>ensus tract-level pharmacy<\/ins><ins> desert or has a medically underserved designation;<\/ins><\/p>\n<p class=section><ins>3. Has a high concentration of households b<\/ins><ins>elow 200 percent of the federal poverty level;<\/ins><\/p>\n<p class=section><ins>4. Has a high <\/ins><ins>prevalence<\/ins><ins> of ambulatory care-sensitive conditions;<\/ins><\/p>\n<p class=section><ins>5. Has a population with a high Medicaid or<\/ins><ins> Family Access to Medical Insurance Security plan<\/ins><ins> enrollment;<\/ins><\/p>\n<p class=section><ins>6. <\/ins><ins>Experiences workforce shortages or pharmacy staffing instab<\/ins><ins>i<\/ins><ins>lity and turnover;<\/ins><\/p>\n<p class=section><ins>7. Faces significant tra<\/ins><ins>nsportatio<\/ins><ins>n or other barriers to safely accessing pharmacy services; or<\/ins><\/p>\n<p class=section><ins>8.<\/ins><ins> Sees patterns of historical disinvestment or inequitable health outcomes.<\/ins><\/p>\n<p class=section><ins>B. During this phase, the Department shall consult with relevant agencies, schools of pharmacy, and community health <\/ins><ins>partners<\/ins><ins> to assess risks of pharmacy closure<\/ins><ins>s<\/ins><ins> and identify feasible interventions to avoid such closures.<\/ins><ins> <\/ins><ins>The Department shall develop a planning report describing identified communities, proposed interventions, selection criteria, and recommendations for <\/ins><ins>Program implementation<\/ins><ins>, as described in \u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.11\/'>32.1-23.11<\/a>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.1\/'>32.1-23.1<\/a><\/ins><ins>0<\/ins><ins>. P<\/ins><ins>rogram<\/ins><ins> implementation<\/ins><ins>; contingent upon funding<\/ins><ins>; participation limit<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. The <\/ins><ins>implementation<\/ins><ins> of the Program is contingent upon (i) express <\/ins><ins>appropriation<\/ins><ins> by the General <\/ins><ins>Assembly<\/ins><ins> or (ii) written certification by the Commission that sufficient nongeneral funds have been secured for such implementation.<\/ins><ins> <\/ins><ins>The Department shall pursue nongeneral funds before requesting general fu<\/ins><ins>nd support.<\/ins><ins> <\/ins><ins>Participation in the Program is limited to no more than 12 independent pharmacies.<\/ins><ins> Such participation is voluntary and shall not guarantee future funding.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>Support for a Program <\/ins><ins>participant<\/ins><ins> may include <\/ins><ins>(i) technical <\/ins><ins>assistance<\/ins><ins> for clinical service expansion; (ii) workflow optimization; (iii) revenue cycle support; (iv) technology integration; (v) limited and capped <\/ins><ins>stabilization<\/ins><ins> grants; (vi) <\/ins><ins>partnership<\/ins><ins> development with hea<\/ins><ins>lth systems<\/ins><ins>,<\/ins><ins> <\/ins><ins>federally<\/ins><ins> qualified health centers, health departments, or academic partners; (vii) assistance in accessing alternative funding streams; or (viii) any other activity consistent with the purposes of this article.<\/ins><ins> The Department may contract with academic institutions, community health organizations, professional associations, nonprofit entities, and qualified evaluators to support Program administration and technical assistance.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.1\/'>32.1-23.1<\/a><\/ins><ins>1<\/ins><ins>. Program selection criteria.<\/ins><\/p>\n<p class=section><ins>Priority for Program participation shall be given to independent pharmacies that:<\/ins><\/p>\n<p class=section><ins>1. Are independently<\/ins><ins> owned and not a part of a national chain;<\/ins><\/p>\n<p class=section><ins>2. Serve medically underserved communities or communities experiencing barriers to<\/ins><ins> pharmacy<\/ins><ins> access;<\/ins><\/p>\n<p class=section><ins>3. Serve populations <\/ins><ins>that are economically vulnerable;<\/ins><\/p>\n<p class=section><ins>4. Demonstrate workforce strain or risk of closure;<\/ins><\/p>\n<p class=section><ins>5. Serve populations with high burdens of chronic<\/ins><ins> conditions requiring consistent medication access;<\/ins><\/p>\n<p class=section><ins>6. Participate in Medicaid, the Family Access to Medical Insurance Security plan, Medicare Part D, or<\/ins><ins> any other safety-net program;<\/ins><\/p>\n<p class=section><ins>7. Provide or demonstrate capacity to expand clinical services; and<\/ins><\/p>\n<p class=section><ins>8. Agree to participate in <\/ins><ins>and comply with evaluation and data-reporting requirements.<\/ins><\/p>\n<p class=catchln><ins>\u00a7<\/ins><ins> <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.1\/'>32.1-23.1<\/a><\/ins><ins>2<\/ins><ins>. Evaluation<\/ins><ins> criteria; report<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. The Department shall evaluate:<\/ins><\/p>\n<p class=section><ins>1. Access to pharmacy services;<\/ins><\/p>\n<p class=section><ins>2. Medication adherence;<\/ins><\/p>\n<p class=section><ins>3. <\/ins><ins>Emergency department utilization for ambulatory care-sensitive conditions;<\/ins><\/p>\n<p class=section><ins>4. Avoidable hospitalizations associated with gaps in medication access;<\/ins><\/p>\n<p class=section><ins>5. Access to vaccinations and preventive services;<\/ins><\/p>\n<p class=section><ins>6. Pharmacy workforce <\/ins><ins>stability;<\/ins><\/p>\n<p class=section><ins>7. Potential cost avoidance for public health programs; and<\/ins><ins><s> <\/s><\/ins><\/p>\n<p class=section><ins>8. Development of susta<\/ins><ins>inable clinical, technological, or partnership infrastructure.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>The Department shall submit to the Governor and the General <\/ins><ins>Assembly an interim report with such evaluation data no later than November 1, 2028<\/ins><ins>,<\/ins><ins> and a final comprehensive evaluation no later than November 1, 2029.<\/ins><ins> Such reports shall be used to determine whether to continue, modify, expand, or terminate the Program.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.1\/'>32.1-23.1<\/a><\/ins><ins>3<\/ins><ins>. Nongeneral <\/ins><ins>fund authority; limitations.<\/ins><\/p>\n<p class=section><ins>The Department may seek, accept, and expend federal grants, charitable contributions, and other nongeneral fund resources to support the Program. Nothi<\/ins><ins>ng in this article shall be construed to (i) create an entitlement to funding; (ii) establish mandates on insurers or pharmacy benefit managers; (iii) require general fund appropriations; (iv) modify licensure authority; or (v) create liability for pharmacy closures.<\/ins><\/p>\n<p class=enactcls>2. That the provisions of this act shall expire on July 1, 2030.<\/p>",
"catch_line": "Independent Pharmacy Access and Resilience Pilot Program; established, report, sunset.",
"duplicates": null,
"session_id": 32,
"word_count": 1374,
"patron_party": "D",
"patron_place": "Norfolk",
"summary_hash": "57e3000bab4a42f9bfe558b0ac3e1afb",
"patron_prefix": "Del.",
"patron_suffix": "(D-Norfolk)",
"status_detail": "failed committee",
"_rsun_versions": [
{
"id": "418b99b3659fe3adf962d3c9cc500b2cb4f3a8ba5e1851d53b5fbb1c776e1346",
"code": "HB335",
"bill_id": 84135,
"source_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb335.pdf",
"source_date": "2026-01-11",
"source_hash": "07c5e65b4ea24e24d123ec11efaa9e6786776e965dda37b3ecb0a36a1a59b790",
"source_html": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=enactcls>1. That the Code of Virginia is amended by adding in Chapter 1 of Title 32.1 an article numbered 3.1, consisting of sections numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.8\/'>32.1-23.8<\/a> through <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.13\/'>32.1-23.13<\/a>, as follows:<\/p>\n<p class=textctr><ins>Article <\/ins><ins>3.1<\/ins><ins>.<\/ins><\/p>\n<p class=textctr><ins>Independent Pharmacy Access and Resilience Pilot Program<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23\/'>32.1-23<\/a>.<\/ins><ins>8<\/ins><ins>.<\/ins><ins> Independent Pharmacy Access and Resilience Pilot Program<\/ins><ins> established<\/ins><ins>; purpose.<\/ins><\/p>\n<p class=section><ins>There is hereby created in the Department the Independent Pharmacy Access and Resilience Pilot Program (the Program)<\/ins><ins>. The purpose of the Program is<\/ins><ins> to strengthen and stabilize access to pharmacy services in medically underserved communities and communities at heightened risk of pharmacy closure. The Program shall support development of sustainable pharmacy infrastructure, expansion of clinical services within pharmacists' scope of practice, partnership development, and implementation of technology that improves access, efficiency, and care coordination.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23\/'>32.1-23<\/a>.<\/ins><ins>9<\/ins><ins>. <\/ins><ins>Pre-implementation <\/ins><ins>phase:<\/ins><ins> preliminary <\/ins><ins>identification <\/ins><ins>of communities,<\/ins><ins>and planning<\/ins><ins>; report<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>During <\/ins><ins>f<\/ins><ins>iscal <\/ins><ins>y<\/ins><ins>ear 2026<\/ins><ins>\u2013<\/ins><ins>2027,<\/ins><ins> using currently existing appropriated funds,<\/ins><ins> the Department shall engage in<\/ins><ins> the <\/ins><ins>identification of <\/ins><ins>communities<\/ins><ins> with limited pharmacy access, including those that meet <\/ins><ins>one or more of the following criteria:<\/ins><\/p>\n<p class=section><ins>1. <\/ins><ins>Is a w<\/ins><ins>hole-locality pharmacy desert<\/ins><ins> <\/ins><ins>status;<\/ins><\/p>\n<p class=section><ins>2. <\/ins><ins>Is a c<\/ins><ins>ensus tract-level pharmacy<\/ins><ins> desert or has a medically underserved designation;<\/ins><\/p>\n<p class=section><ins>3. Has a high concentration of households b<\/ins><ins>elow 200 percent of the federal poverty level;<\/ins><\/p>\n<p class=section><ins>4. Has a high <\/ins><ins>prevalence<\/ins><ins> of ambulatory care-sensitive conditions;<\/ins><\/p>\n<p class=section><ins>5. Has a population with a high Medicaid or<\/ins><ins> Family Access to Medical Insurance Security plan<\/ins><ins> enrollment;<\/ins><\/p>\n<p class=section><ins>6. <\/ins><ins>Experiences workforce shortages or pharmacy staffing instab<\/ins><ins>i<\/ins><ins>lity and turnover;<\/ins><\/p>\n<p class=section><ins>7. Faces significant tra<\/ins><ins>nsportatio<\/ins><ins>n or other barriers to safely accessing pharmacy services; or<\/ins><\/p>\n<p class=section><ins>8.<\/ins><ins> Sees patterns of historical disinvestment or inequitable health outcomes.<\/ins><\/p>\n<p class=section><ins>B. During this phase, the Department shall consult with relevant agencies, schools of pharmacy, and community health <\/ins><ins>partners<\/ins><ins> to assess risks of pharmacy closure<\/ins><ins>s<\/ins><ins> and identify feasible interventions to avoid such closures.<\/ins><ins> <\/ins><ins>The Department shall develop a planning report describing identified communities, proposed interventions, selection criteria, and recommendations for <\/ins><ins>Program implementation<\/ins><ins>, as described in \u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.11\/'>32.1-23.11<\/a>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.1\/'>32.1-23.1<\/a><\/ins><ins>0<\/ins><ins>. P<\/ins><ins>rogram<\/ins><ins> implementation<\/ins><ins>; contingent upon funding<\/ins><ins>; participation limit<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. The <\/ins><ins>implementation<\/ins><ins> of the Program is contingent upon (i) express <\/ins><ins>appropriation<\/ins><ins> by the General <\/ins><ins>Assembly<\/ins><ins> or (ii) written certification by the Commission that sufficient nongeneral funds have been secured for such implementation.<\/ins><ins> <\/ins><ins>The Department shall pursue nongeneral funds before requesting general fu<\/ins><ins>nd support.<\/ins><ins> <\/ins><ins>Participation in the Program is limited to no more than 12 independent pharmacies.<\/ins><ins> Such participation is voluntary and shall not guarantee future funding.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>Support for a Program <\/ins><ins>participant<\/ins><ins> may include <\/ins><ins>(i) technical <\/ins><ins>assistance<\/ins><ins> for clinical service expansion; (ii) workflow optimization; (iii) revenue cycle support; (iv) technology integration; (v) limited and capped <\/ins><ins>stabilization<\/ins><ins> grants; (vi) <\/ins><ins>partnership<\/ins><ins> development with hea<\/ins><ins>lth systems<\/ins><ins>,<\/ins><ins> <\/ins><ins>federally<\/ins><ins> qualified health centers, health departments, or academic partners; (vii) assistance in accessing alternative funding streams; or (viii) any other activity consistent with the purposes of this article.<\/ins><ins> The Department may contract with academic institutions, community health organizations, professional associations, nonprofit entities, and qualified evaluators to support Program administration and technical assistance.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.1\/'>32.1-23.1<\/a><\/ins><ins>1<\/ins><ins>. Program selection criteria.<\/ins><\/p>\n<p class=section><ins>Priority for Program participation shall be given to independent pharmacies that:<\/ins><\/p>\n<p class=section><ins>1. Are independently<\/ins><ins> owned and not a part of a national chain;<\/ins><\/p>\n<p class=section><ins>2. Serve medically underserved communities or communities experiencing barriers to<\/ins><ins> pharmacy<\/ins><ins> access;<\/ins><\/p>\n<p class=section><ins>3. Serve populations <\/ins><ins>that are economically vulnerable;<\/ins><\/p>\n<p class=section><ins>4. Demonstrate workforce strain or risk of closure;<\/ins><\/p>\n<p class=section><ins>5. Serve populations with high burdens of chronic<\/ins><ins> conditions requiring consistent medication access;<\/ins><\/p>\n<p class=section><ins>6. Participate in Medicaid, the Family Access to Medical Insurance Security plan, Medicare Part D, or<\/ins><ins> any other safety-net program;<\/ins><\/p>\n<p class=section><ins>7. Provide or demonstrate capacity to expand clinical services; and<\/ins><\/p>\n<p class=section><ins>8. Agree to participate in <\/ins><ins>and comply with evaluation and data-reporting requirements.<\/ins><\/p>\n<p class=catchln><ins>\u00a7<\/ins><ins> <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.1\/'>32.1-23.1<\/a><\/ins><ins>2<\/ins><ins>. Evaluation<\/ins><ins> criteria; report<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. The Department shall evaluate:<\/ins><\/p>\n<p class=section><ins>1. Access to pharmacy services;<\/ins><\/p>\n<p class=section><ins>2. Medication adherence;<\/ins><\/p>\n<p class=section><ins>3. <\/ins><ins>Emergency department utilization for ambulatory care-sensitive conditions;<\/ins><\/p>\n<p class=section><ins>4. Avoidable hospitalizations associated with gaps in medication access;<\/ins><\/p>\n<p class=section><ins>5. Access to vaccinations and preventive services;<\/ins><\/p>\n<p class=section><ins>6. Pharmacy workforce <\/ins><ins>stability;<\/ins><\/p>\n<p class=section><ins>7. Potential cost avoidance for public health programs; and<\/ins><ins><s> <\/s><\/ins><\/p>\n<p class=section><ins>8. Development of susta<\/ins><ins>inable clinical, technological, or partnership infrastructure.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>The Department shall submit to the Governor and the General <\/ins><ins>Assembly an interim report with such evaluation data no later than November 1, 2028<\/ins><ins>,<\/ins><ins> and a final comprehensive evaluation no later than November 1, 2029.<\/ins><ins> Such reports shall be used to determine whether to continue, modify, expand, or terminate the Program.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-23.1\/'>32.1-23.1<\/a><\/ins><ins>3<\/ins><ins>. Nongeneral <\/ins><ins>fund authority; limitations.<\/ins><\/p>\n<p class=section><ins>The Department may seek, accept, and expend federal grants, charitable contributions, and other nongeneral fund resources to support the Program. Nothi<\/ins><ins>ng in this article shall be construed to (i) create an entitlement to funding; (ii) establish mandates on insurers or pharmacy benefit managers; (iii) require general fund appropriations; (iv) modify licensure authority; or (v) create liability for pharmacy closures.<\/ins><\/p>\n<p class=enactcls>2. That the provisions of this act shall expire on July 1, 2030.<\/p>",
"source_metadata": {
"bodyAssociation": "archive-reported-current-version",
"archiveReference": {
"date": "2026-01-11",
"number": "HB335",
"pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb335.pdf"
}
}
}
],
"copatron_count": 8,
"patron_address": [
"P.O. Box 1853",
"Norfolk",
"VA 23501"
],
"patron_chamber": "house",
"patron_started": 2024,
"session_lis_id": 261,
"status_history": [
{
"date": "02\/18\/2026",
"status": "Left in Committee Appropriations",
"date_raw": "2026-02-18",
"vote_count": null,
"lis_vote_id": null,
"translation": "failed committee"
},
{
"date": "02\/06\/2026",
"status": "Subcommittee recommends laying on the table (7-Y 0-N)",
"date_raw": "2026-02-06",
"vote_count": null,
"lis_vote_id": "295277",
"translation": "failed subcommittee"
},
{
"date": "02\/05\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (HB335)",
"date_raw": "2026-02-05",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "01\/22\/2026",
"status": "Assigned HAPP sub: Health & Human Resources",
"date_raw": "2026-01-22",
"vote_count": null,
"lis_vote_id": null,
"translation": "in subcommittee"
},
{
"date": "01\/22\/2026",
"status": "Reported from Health and Human Services and referred to Appropriations (21-Y 1-N)",
"date_raw": "2026-01-22",
"vote_count": null,
"lis_vote_id": "291828",
"translation": "passed committee"
},
{
"date": "01\/20\/2026",
"status": "Subcommittee recommends reporting and referring to Appropriations (9-Y 0-N)",
"date_raw": "2026-01-20",
"vote_count": null,
"lis_vote_id": "291568",
"translation": "passed subcommittee"
},
{
"date": "01\/20\/2026",
"status": "Subcommittee recommends reporting and referring to Appropriations",
"date_raw": "2026-01-20",
"vote_count": null,
"lis_vote_id": null,
"translation": "passed subcommittee"
},
{
"date": "01\/16\/2026",
"status": "Assigned sub: Health",
"date_raw": "2026-01-16",
"vote_count": null,
"lis_vote_id": null,
"translation": "in subcommittee"
},
{
"date": "01\/11\/2026",
"status": "Referred to Committee on Health and Human Services",
"date_raw": "2026-01-11",
"vote_count": null,
"lis_vote_id": null,
"translation": "in committee"
},
{
"date": "01\/11\/2026",
"status": "Committee Referral Pending",
"date_raw": "2026-01-11",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "01\/11\/2026",
"status": "Prefiled and ordered printed; Offered 01-14-2026 26103250D",
"date_raw": "2026-01-11",
"vote_count": null,
"lis_vote_id": null,
"translation": "introduced"
}
],
"chief_patron_id": 494,
"date_introduced": "2026-01-11",
"patron_district": 92,
"patron_shortname": "bganthony",
"committee_chamber": "house",
"status_detail_date": "02\/18\/2026",
"committee_shortname": "appropriations",
"patron_name_formatted": "Del. Bonita Anthony (D-Norfolk)"
}